Diabetes Care Market Expansion Continues, with Forecast Valuation of $40.55 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Diabetes Care Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The diabetes care sector has experienced robust expansion lately, projected to climb from $26.79 billion in 2024 to $29.09 billion in 2025, reflecting an 8.6% compound annual growth rate. This past expansion trend is fueled by several key factors, including escalating rates of obesity, increasing consumer appetite for devices offering continuous monitoring capabilities, greater capital infusion into diabetes-focused research and development efforts, and a broadening need for tailored diabetes management solutions.

Diabetes Care Market Size Forecast: What's the Projected Valuation by 2029?
Anticipating substantial expansion, the market dedicated to diabetes treatment is projected to achieve a valuation of $40.55 billion by the year 2029, exhibiting a consistent compound annual growth rate (CAGR) of 8.7% throughout the projection timeframe, a rise underpinned by the escalating incidence of diabetes globally, a swelling elderly demographic, heightened consciousness regarding effective diabetes control procedures, and improved availability of medical services within emerging economies, complemented by significant market shifts such as the introduction of sophisticated diabetes monitoring technologies, the incorporation of artificial intelligence within care protocols, progress within mechanisms for insulin delivery, and the creation of intelligent insulin-related apparatuses.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetes-care-global-market-report

What Are the Drivers Transforming the Diabetes Care Market?
The projected expansion of the diabetes care sector is anticipated to be fueled by the escalating prevalence of obesity across populations; this measurement, defined as the proportion of individuals exhibiting a Body Mass Index (BMI) at or above 30, signifies obesity, and its rise is attributed to a greater adoption of inactive lifestyles alongside the pervasive accessibility and consumption of nutrient-poor, energy-rich processed foodstuffs, resulting in an energy imbalance relative to physical exertion. Furthermore, diabetes management becomes integral in confronting these rising obesity statistics by advocating for superior lifestyle habits, enhancing blood sugar regulation, and fostering weight management through sophisticated interventions like insulin administration and ongoing glucose tracking technologies; as an illustration, data released by the World Health Organization, an international body headquartered in Switzerland, in March 2024 indicated that in 2022, the global figures included 390 million adults classified as underweight alongside 2.5 billion adults deemed overweight, a category comprising 890 million people classified as obese, thereby establishing a direct correlation between expanding obesity figures and the vitality of the diabetes care market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24206&type=smp

What Long-Term Trends Will Define the Future of the Diabetes Care Market?
Leading enterprises within the diabetes management sector are prioritizing the creation of cutting-edge solutions, notably Automated Insulin Delivery (AID) systems, aiming to enhance blood sugar regulation through the fusion of continuous glucose monitoring (CGM) devices and insulin pumps to facilitate instantaneous modifications. An AID system represents a technological leap, marrying a CGM with an insulin pump, allowing for autonomous insulin dosing calibrated by immediate glucose readings, thereby optimizing diabetes control. Illustratively, in February of 2024, Tandem Diabetes Care Inc., an American producer of diabetes medical apparatus, launched the Tandem Mobi, positioning it as the most compact yet durable automated insulin dispensing unit globally for diabetic individuals. This novel apparatus features a subtle, tethered insulin pump entirely manageable through a mobile application, granting wearers autonomy over their diabetes care without reliance on conventional remote controls. Furthermore, the Tandem Mobi boasts water resistance and rechargeability, and it seamlessly interfaces with the Dexcom CGM apparatus to execute automated insulin administration leveraging Tandem's established Control-IQ mechanism.

Which Segments in the Diabetes Care Market Offer the Most Profit Potential?
The diabetes caremarket covered in this report is segmented -

1) By Product Type: Glucose Monitoring Devices; Insulin Pumps; Other Product Types
2) By Diabetes Type: Type 2 Diabetes; Type 1 Diabetes; Other Diabetes Type
3) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Care Settings; Other End Users

Subsegments:
1) By Glucose Monitoring Devices: Blood glucose monitoring (BGM); Continuous glucose monitoring (CGM); Flash glucose monitoring (FGM)
2) By Insulin Pumps: Patch pump; Tethered pump; Implanted insulin pump

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24206&type=smp

Which Firms Dominate the Diabetes Care Market by Market Share and Revenue in 2025?
Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.

Which Regions Offer the Highest Growth Potential in the Diabetes Care Market?
North America was the largest region in the diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24206

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.